Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.

作者: Ignace Vergote , Gabriele Elser , Benedicte Votan , Laura Farrelly , Joke De Roover

DOI: 10.1097/IGC.0B013E31829B87DA

关键词:

摘要: The European Network for Gynaecological Oncological Trial groups (ENGOT) is a research network of the Society Oncology and was founded in Berlin October 2007. Earlier, we reported on ENGOT minimal requirements trials between academic pharmaceutical companies. In this paper, summarize roadmap performing framework. roadmap, define how an trial should be set up discuss following items: What are conditions to classify study as trial? protocol? How protocol, informed consent (ICF), case report form (CRF) produced? center selection feasibility performed trials? regulatory operational tasks handled? confidentiality agreement industry whole negotiated? contracts made groups? funding, insurance, communication flow ar- ranged conducting substudies what leading group A template agreement, checklist criteria new proposals, guidelines authorship also provided.

参考文章(1)
Ignace Vergote, Eric Pujade-Lauraine, Sandro Pignata, Gunnar B. Kristensen, Jonathan Ledermann, Antonio Casado, Jalid Sehouli, Mansoor Mirza, Roldano Fossati, Christian Marth, Carine Creutzberg, Jose Del Campo, Nadeem Siddiqui, Paula Calvert, Aris Bamias, Gokhan Tulunay, Ate G.J. van der Zee, Andreas du Bois, European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies International Journal of Gynecological Cancer. ,vol. 20, pp. 476- 478 ,(2010) , 10.1111/IGC.0B013E3181D3CAA8